Interfascial Infiltration for Acute Unspecific Low Back Pain in the Emergency Department

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

February 1, 2019

Study Completion Date

February 25, 2019

Conditions
Low Back PainAcute
Interventions
OTHER

Interfascial infiltration

"Injection of L-bupivacaine (50 mg) and dexamethasone (4 mg) in the interfascial space under ultrasound guidance.~Patients were kept under surveillance for at least one hour before discharge.~Patients were discharged home with a 7 day supply of acetaminophen 1000 mg orally every 6 h, ketoprofen 100 mg, orally twice a day, and muscle relaxant as needed. Patients were instructed to take tramadol 50 mg, orally every 6h as needed for low back pain, in case of insufficient relief."

OTHER

Standard medical treatment

"Standard medical treatment include acetaminophen, NSAIDs and muscle relaxant as first line pharmacological treatment and escalation to analgesics level II or morphine if required, as needed for low back pain, in agreement with national guidelines Route of administration (orally or iv) was let at the discretion of the attending emergency physician.~Patients were kept under surveillance for one hour before discharge. Patients were discharged home with a 7 day supply of acetaminophen 1000 mg orally every 6h, ketoprofen 100 mg, orally twice a day, and muscle relaxant as needed. Patients were instructed to take tramadol 50 mg, orally every 6h as needed for low back pain, in case of insufficient relief."

Trial Locations (1)

34295

Uh Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03968185 - Interfascial Infiltration for Acute Unspecific Low Back Pain in the Emergency Department | Biotech Hunter | Biotech Hunter